RSS News

Pharmaceutical Industry

Drugs Licensed

ArriVent BioPharma Secures Global Rights to Promising Cancer Drug MRG007 in $1.2B Deal - StockTitan

FDA beats EMA to most approved new drugs in 2024 - Pharmaceutical Technology

The Possible Dangers of Buying Medicines Over the Internet - FDA.gov

CDER drug approvals U.S. 2008-2024 - Statista

Probationer With a Suspended License Gets Caught Driving With Drugs - Newstalkkgvo

Prescription Drug Costs | Pros, Cons, Debate, Arguments, Economy, Laws, Government, & Regulation - Britannica

Simulations Plus Supported Development of Majority of FDA-Approved Drugs in 2024 - Yahoo Finance

Pharmacist to have license revoked after admitting to filling out fake prescriptions for himself - WNEM

In weight loss battle, Novo and Lilly face growing offensive from licensed copies - Reuters

Drugs Patents

he Law and Politics of Drug Price Controls and Pharmaceutical Innovation - IPWatchdog.com

Advocates Slam US-Gilead Patent Settlement Over HIV PrEP Drugs - Bloomberg Law

Gilead Sciences, US government settle patent case over HIV prevention drugs - Reuters

$52.6 Billion: Extra Cost to Consumers of Add-On Drug Patents - UCLA

Gilead settles with US government in long-running patent dust-up over PrEP meds Truvada, Descovy - FiercePharma

Should Patents Create Incentives for Failure? - The Regulatory Review

RAI Explainer: Generic Drugs, Property Rights, and the Orange Book - Center for Strategic & International Studies

Gilead Settles HIV Drug Lawsuit Over Patent on Truvada and Descovy - AboutLawsuits.com

Patent bills could end up costing patients more at the pharmacy shelves - PIRG

Drugs Generics

FTC report reveals PBMs inflate costs of specialty generic drugs - TechTarget

Trump rescinds Biden executive order on prescription drugs: How will it affect prices? - WPTV News Channel 5 West Palm

Importing Generic Drugs Could Ease U.S. Shortages - Think Global Health

China Looks Into Generic Drug Quality After Doctors Speak Up - Bloomberg

What Is a Generic Drug? - Health Essentials

Industrial Policy To Reduce Prescription Generic Drug Shortages - Center For American Progress

PBMs made more than $7B marking up specialty generics: FTC - Axios

Clearing the Path for New Uses for Generic Drugs - Federation of American Scientists

OPINION: Tariffs on generic drugs will Increase drug shortages - Southgate News Herald

FDA Food and Drug Administration

FDA approves Johnson & Johnson’s nasal spray for depression as stand-alone treatment - CNBC

Three former FDA officials: Here’s what Trump and his nominees need to know - STAT

US FDA puts clinical hold on Atara's trials for cancer cell therapies - Reuters

Fresh from the biotech pipeline: FDA approvals settle in 2024, but what next? - Nature.com

FDA approves first nasal spray for major depression disorder - KSAT San Antonio

RFK Jr. wants to improve Americans' health. Here's some advice from the outgoing FDA chief - Los Angeles Times

Food companies want to confuse consumers. The FDA must push back. - The Hill

Disc set to spin up confirmatory trial, seek approval after ironing out details with FDA - Fierce Biotech

Nose spray to treat depression? FDA approves first-of-its-kind medicine - WJTV

Pharmaceutical Companies

Got $500? 2 Pharmaceutical Stocks to Buy and Hold Forever - The Motley Fool

Beaten Down Under Biden, Big Pharma Hopes for New Chapter Under Trump - The Wall Street Journal

Healthy Returns: Biotech and pharma M&A is off to a good start in 2025 — but will it last? - CNBC

Early-stage biotechs may soon get their swagger back, say industry leaders - The Business Journals

Sanofi is warned by the FDA over ‘significant’ problems at a key manufacturing plant - STAT

Jim Cramer on Regeneron Pharmaceuticals, Inc. (REGN): ‘This Company Has Never Lost Its Ability To Develop New Medicines’ - Yahoo Finance

U.S. Pharmaceutical CDMO Market Size to Surpass 83.25 Bn by 2034 - BioSpace

Ritedose and Newberry College Forge Strategic Partnership to Launch Pharmaceutical Manufacturing Program - Morningstar

The Clock is Ticking: Preparing for DSCSA Data Interoperability Deadlines - Contract Pharma

Retail Pharmacies

Empowering the Future of Pharmacy and Retail: Key takeaways from “NACDS Regional” on industry challenges and innovations - NewsBreak

Will PBM reform save pharmacies from closing? - STAT

Nearly 1 in 3 retail pharmacies have closed since 2010 - UC Berkeley School of Public Health

Pharmacies seek new strategies amid store closures and market disruption - BenefitsPro

Facing the challenges: Retail pharmacies evolve to overcome the hurdles of a changing industry - REjournals.com

Bill would prevent PBMs from dispensing drugs via retail, mail - talkbusiness.net

About 1 in 3 retail pharmacies have closed since 2010: study - Healthcare Dive

How retail pharmacies are bringing clinical trials to the community - Association of Health Care Journalists

UCSF Health Opens New Outpatient Pharmacies in San Francisco - UC San Francisco

Drug Marketing

Online marketing for compounded GLP-1 drugs overstates benefits and underplays risks - STAT

What Are Barriers to Entry for Pharma Companies? - Investopedia

Shandong Xinhua Pharmaceutical Secures Approval for Drug Marketing Authorization Transfer - TipRanks

Prescription Drug Costs | Pros, Cons, Debate, Arguments, Economy, Laws, Government, & Regulation - Britannica

Otsuka falls foul of most serious drug marketing breach, again, as Jinarc training site comes under fire - FiercePharma

Market Report 2025: Pharmaceutical Manufacturing - News-Medical.Net

Prescription drug expenditure in the U.S. 1960-2024 - Statista

Evaluation of Companion Diagnostics in Scientific Advice and Drug Marketing Authorization Applications by the European Medicines Agency - Frontiers

6 things you should know about drug marketing authorizations (MA) - Servier